METHOD FOR CORRECTION OF SECONDARY MUCOCILIARY INSUFFICIENCY OF UPPER AIRWAY IN PATIENTS WITH BRONCHOPULMONARY DISEASES Russian patent published in 2015 - IPC A61N5/67 A61B5/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to pulmonology, and can be used for the correction of secondary mucociliary insufficiency (MCI) of the upper airway (UA) in the patients with bronchopulmonary diseases. Mucous membranes of the nasal cavity from both sides are exposed to a low level red light laser therapy at wave length of 0.633 mcm in a continuous mode. That are preceded by diagnosing and determining degrees of the SMCI. Degree 1 secondary mucociliary insufficiency of the upper airway requires the laser light exposure at total power density (PD) 1.5 J/cm² by 5 or 6 1-minute sessions. Degree 2 implies 1.5-minute sessions in number of 7 or 8 at total PD 2.25 J/cm². If observing degree 3, 9 or 10 daily sessions last for 2 minutes every day at total PD 3.0 J/cm².

EFFECT: method enables providing the higher clinical effectiveness by the differentiated use of LLLT depending on a degree of secondary MCI and restoring the mucociliary transport.

5 tbl, 4 ex